Who is sponsoring NCT05484934?

NCT05484934 is sponsored by BioAesthetics.

What drugs are being tested in NCT05484934?

Interventions in NCT05484934: Regenerative post mastectomy surgery.

What condition does NCT05484934 study?

NCT05484934 studies Post-Mastectomy Breast Deformity (Disorder).

Is NCT05484934 still recruiting?

NCT05484934 is currently status unknown. Last updated 14 October 2022.

Last reviewed 2022-10-14 · How we verify

NCT05484934

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigate Wound Healing, Aesthetics & Pt Satisfaction Post NAC Reconstruction Using a Decellularized Donor NAC Graft

Status unknown NA Last updated 14 October 2022

What this trial tests

NA trial testing Regenerative post mastectomy surgery in Post-Mastectomy Breast Deformity (Disorder) in 36 participants. Status unknown.

Timeline

21 September 2022

Primary endpoint
7 August 2024

7 October 2024

Quick facts

Lead sponsor	BioAesthetics
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	36
Start date	21 September 2022
Primary completion	7 August 2024
Estimated completion	7 October 2024
Sites	1 location across United States

Drugs / interventions tested

Regenerative post mastectomy surgery

Conditions studied

Post-Mastectomy Breast Deformity (Disorder) — all drugs for Post-Mastectomy Breast Deformity (Disorder) →

Sponsor

BioAesthetics

Who can join

Adults 18 to 65, female only, with Post-Mastectomy Breast Deformity (Disorder). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the wound healing response following nipple-areolar complex (NAC) reconstruction with a decellularized donor NAC graft (DCLNAC)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05484934 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by BioAesthetics
Last refreshed: 14 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05484934.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing